1. Home
  2. MDGL vs CHRD Comparison

MDGL vs CHRD Comparison

Compare MDGL & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CHRD
  • Stock Information
  • Founded
  • MDGL 2011
  • CHRD 2007
  • Country
  • MDGL United States
  • CHRD United States
  • Employees
  • MDGL N/A
  • CHRD N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CHRD Oil & Gas Production
  • Sector
  • MDGL Health Care
  • CHRD Energy
  • Exchange
  • MDGL Nasdaq
  • CHRD Nasdaq
  • Market Cap
  • MDGL 6.8B
  • CHRD 5.5B
  • IPO Year
  • MDGL N/A
  • CHRD 2010
  • Fundamental
  • Price
  • MDGL $295.36
  • CHRD $99.43
  • Analyst Decision
  • MDGL Strong Buy
  • CHRD Buy
  • Analyst Count
  • MDGL 10
  • CHRD 12
  • Target Price
  • MDGL $420.63
  • CHRD $153.83
  • AVG Volume (30 Days)
  • MDGL 374.9K
  • CHRD 775.4K
  • Earning Date
  • MDGL 05-01-2025
  • CHRD 05-06-2025
  • Dividend Yield
  • MDGL N/A
  • CHRD 8.23%
  • EPS Growth
  • MDGL N/A
  • CHRD N/A
  • EPS
  • MDGL N/A
  • CHRD 15.19
  • Revenue
  • MDGL $317,383,000.00
  • CHRD $5,036,741,000.00
  • Revenue This Year
  • MDGL $264.55
  • CHRD N/A
  • Revenue Next Year
  • MDGL $67.21
  • CHRD $0.27
  • P/E Ratio
  • MDGL N/A
  • CHRD $6.56
  • Revenue Growth
  • MDGL N/A
  • CHRD 31.78
  • 52 Week Low
  • MDGL $200.08
  • CHRD $79.83
  • 52 Week High
  • MDGL $377.46
  • CHRD $188.02
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.64
  • CHRD 57.06
  • Support Level
  • MDGL $287.46
  • CHRD $88.35
  • Resistance Level
  • MDGL $307.54
  • CHRD $100.47
  • Average True Range (ATR)
  • MDGL 16.74
  • CHRD 2.87
  • MACD
  • MDGL -2.04
  • CHRD 1.25
  • Stochastic Oscillator
  • MDGL 12.84
  • CHRD 91.44

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.

Share on Social Networks: